Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 6
2005 6
2006 4
2007 2
2011 4
2012 4
2013 6
2014 6
2015 7
2016 2
2017 5
2018 2
2019 4
2020 2
2021 3
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for meifeng tu
Search for Meiting Tu instead (3 results)
A safe and potent anti-CD19 CAR T cell therapy.
Ying Z, Huang XF, Xiang X, Liu Y, Kang X, Song Y, Guo X, Liu H, Ding N, Zhang T, Duan P, Lin Y, Zheng W, Wang X, Lin N, Tu M, Xie Y, Zhang C, Liu W, Deng L, Gao S, Ping L, Wang X, Zhou N, Zhang J, Wang Y, Lin S, Mamuti M, Yu X, Fang L, Wang S, Song H, Wang G, Jones L, Zhu J, Chen SY. Ying Z, et al. Among authors: tu m. Nat Med. 2019 Jun;25(6):947-953. doi: 10.1038/s41591-019-0421-7. Epub 2019 Apr 22. Nat Med. 2019. PMID: 31011207 Free PMC article. Clinical Trial.
Primary mediastinal large B cell lymphoma.
Yu Y, Dong X, Tu M, Wang H. Yu Y, et al. Among authors: tu m. Thorac Cancer. 2021 Nov;12(21):2831-2837. doi: 10.1111/1759-7714.14155. Epub 2021 Sep 29. Thorac Cancer. 2021. PMID: 34590432 Free PMC article. Review.
Efficacy and safety of relmacabtagene autoleucel, an anti-CD19 chimeric antigen receptor T cell, in relapsed/refractory B-cell non-Hodgkin's lymphoma: 2-year results of a phase 1 trial.
Ying Z, Xie Y, Zheng W, Liu W, Lin N, Tu M, Wang X, Ping L, Deng L, Zhang C, Wu M, Feng F, Du T, Tang Y, Su F, Guo Z, Li J, Song Y, Zhu J. Ying Z, et al. Among authors: tu m. Bone Marrow Transplant. 2023 Mar;58(3):288-294. doi: 10.1038/s41409-022-01888-z. Epub 2022 Dec 7. Bone Marrow Transplant. 2023. PMID: 36477110 Clinical Trial.
Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease.
Yu L, Tu M, Cortes J, Xu-Monette ZY, Miranda RN, Zhang J, Orlowski RZ, Neelapu S, Boddu PC, Akosile MA, Uldrick TS, Yarchoan R, Medeiros LJ, Li Y, Fajgenbaum DC, Young KH. Yu L, et al. Among authors: tu m. Blood. 2017 Mar 23;129(12):1658-1668. doi: 10.1182/blood-2016-11-748855. Epub 2017 Jan 18. Blood. 2017. PMID: 28100459 Free PMC article.
[Prognostic value of 18F-FDG PET-CT in Hodgkin lymphoma].
Ying Z, Wang X, Song Y, Zheng W, Wang X, Xie Y, Lin N, Tu M, Ping L, Liu W, Deng L, Zhang C, Yang Z, Zhu J. Ying Z, et al. Among authors: tu m. Zhonghua Xue Ye Xue Za Zhi. 2014 Apr;35(4):325-7. doi: 10.3760/cma.j.issn.0253-2727.2014.04.016. Zhonghua Xue Ye Xue Za Zhi. 2014. PMID: 24759021 Chinese.
66 results